98%
921
2 minutes
20
ATE1 (arginyltransferase 1; EC 2.3.2) transfers the amino acid arginine (Arg) from Arg-tRNA to the N-terminal (Nt) residues of proteins, such as aspartate (Asp), glutamate (Glu), and oxidized cysteine (Cys). The resulting Nt-Arg acts as an N-degron that regulates the degradation of various biomaterials via the ubiquitin/Ub-proteasome system (UPS) or the autophagy-lysosome system (ALS). In the UPS, Arg/N-degrons are recognized by cognate N-recognins, leading to substrate ubiquitination and proteasomal degradation. In the ALS, the same degrons bind the macroautophagy/autophagy receptor SQSTM1/p62 (sequestosome 1) to facilitate self-polymerization of SQSTM1 associated with cargoes and SQSTM1 interaction with LC3-II on phagophores. A key unresolved question is why only a small subset of proteins acquires Arg/N-degrons, given the rather weak binding affinity of ATE1 for Nt-substrates. In this study, we determined the cryo-EM structures of human ATE1 in complex with Arg-tRNA and an Nt-Asp peptide. ATE1 harbors two adjacent pockets that each bind an Nt-substrate or Arg-tRNA, the latter being wrapped by a long, unstructured loop. In the apo state, two ATE1 monomers form a homodimer. ATE1 achieves the selectivity for its peptidyl-ligands through these multivalent interactions, with K values in the micro-molar range. These results reveal the structural principle of Nt-arginylation at the crossroads of the UPS and ALS.: ALS: autophagy-lysosome system; Arg: arginine; Asp: aspartate; ATE1: arginyltransferase 1; Cys: cysteine; CysO(H): Cys sulfinic acid; Glu: glutamate; Nt: N-terminal; UBR: ubiquitin protein ligase E3 component n-recognin; UPS: ubiquitin-proteasome system; ZZ: ZZ-type zinc finger.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/15548627.2025.2473393 | DOI Listing |
Cell Commun Signal
September 2025
Nucleic Acid Therapeutics Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Background: Arginyl-tRNA-protein transferase (ATE1) catalyzes N-terminal arginylation, a regulatory protein modification implicated in various cellular processes, including proliferation, apoptosis, and migration. Although ATE1 has context-dependent roles in cancer, its specific function in breast cancer remains unclear. This study investigates the oncogenic role of ATE1 across multiple breast cancer subtypes and its underlying molecular mechanisms.
View Article and Find Full Text PDFMethods Enzymol
August 2025
Department of Biochemistry, Case Western Reserve University, Cleveland, OH, United States; School of Medicine, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States. Electronic address:
ATE1 is an enzyme that catalyzes the post-translational arginylation of proteins by transferring arginine to acidic residues, such as aspartate and glutamate, located at the N-terminus or on side chains. This modification plays important roles in regulating protein stability and function. The mechanisms underlying substrate and site selection by ATE1 remain unclear.
View Article and Find Full Text PDFMethods Enzymol
August 2025
Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, OH, United States; School of Medicine, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States. Electronic address:
This chapter presents a straightforward method for expressing and purifying recombinant human Arginyl-tRNA-protein transferase 1 (ATE1) from E. coli. ATE1 is an enzyme that catalyzes the transfer of arginine from arginyl-tRNA to the N-terminal or internal Asp or Glu residues of the substrate proteins, a process that regulates protein turnover or function.
View Article and Find Full Text PDFCell Death Dis
August 2025
Department of Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, USA.
Cell death regulation is essential for stress adaptation and/or signal response. Past studies have shown that eukaryotic cell death is mediated by an evolutionarily conserved enzyme, arginyltransferase1 (Ate1). The downregulation of Ate1, as seen in many types of cancer, prominently increases cellular tolerance to a variety of stress conditions.
View Article and Find Full Text PDFSLAS Discov
August 2025
Department of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA. Electronic address:
Arginyltransferase 1 (ATE1) catalyzes post-translational arginylation, a process implicated in protein stability, cellular function, and disease pathology. Dysregulated arginylation is associated with neurodegenerative disorders, cancer, and inflammation. Particularly, the increase of ATE1 activity has been shown to cause cell death in response to acute stress, highlighting ATE1 as a promising therapeutic target.
View Article and Find Full Text PDF